Bio Net Income from 2010 to 2026
| BGMS Stock | 1.01 0.03 3.06% |
Net Loss | First Reported 2014-12-31 | Previous Quarter -1.3 M | Current Value -988 K | Quarterly Volatility 1.6 M |
Check Bio Green financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Green's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.1 K, Interest Expense of 36.8 K or Total Revenue of 36.8 K, as well as many indicators such as Price To Sales Ratio of 2.95, Dividend Yield of 10.29 or Days Sales Outstanding of 1.3 K. Bio financial statements analysis is a perfect complement when working with Bio Green Valuation or Volatility modules.
Bio | Net Income | Build AI portfolio with Bio Stock |
The evolution of Net Income for Bio Green Med provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Bio Green compares to historical norms and industry peers.
Latest Bio Green's Net Income Growth Pattern
Below is the plot of the Net Income of Bio Green Med over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Bio Green Med financial statement analysis. It represents the amount of money remaining after all of Bio Green Med operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Bio Green's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Green's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (11.21 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Bio Net Income Regression Statistics
| Arithmetic Mean | (13,708,076) | |
| Coefficient Of Variation | (35.39) | |
| Mean Deviation | 3,914,526 | |
| Median | (13,186,000) | |
| Standard Deviation | 4,851,891 | |
| Sample Variance | 23.5T | |
| Range | 15.3M | |
| R-Value | (0.03) | |
| Mean Square Error | 25.1T | |
| R-Squared | 0.0008 | |
| Significance | 0.92 | |
| Slope | (26,722) | |
| Total Sum of Squares | 376.7T |
Bio Net Income History
Other Fundumenentals of Bio Green Med
Bio Green Net Income component correlations
About Bio Green Financial Statements
Bio Green shareholders use historical fundamental indicators, such as Net Income, to determine how well the company is positioned to perform in the future. Although Bio Green investors may analyze each financial statement separately, they are all interrelated. The changes in Bio Green's assets and liabilities, for example, are also reflected in the revenues and expenses on on Bio Green's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -12.9 M | -13.5 M | |
| Net Loss | -12.9 M | -13.5 M | |
| Net Loss | (452.22) | (474.83) | |
| Net Income Per E B T | 1.08 | 0.98 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bio Stock Analysis
When running Bio Green's price analysis, check to measure Bio Green's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Green is operating at the current time. Most of Bio Green's value examination focuses on studying past and present price action to predict the probability of Bio Green's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Green's price. Additionally, you may evaluate how the addition of Bio Green to your portfolios can decrease your overall portfolio volatility.